New kinds of treatment.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use; D010703:Phorbol Esters / Q000627:therapeutic use; D059004:Topoisomerase I Inhibitors
D000276:Adjuvants, Immunologic; D019380:Anti-HIV Agents; D004791:Enzyme Inhibitors; D010703:Phorbol Esters; D059004:Topoisomerase I Inhibitors; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D009271:Naltrexone; C070999:prostratin; C033575:murabutide